CorMedix IncNASDAQ:CRMD
- LAST PRICE5.1200
- TODAY'S CHANGE (%)0.0100 (0.1957%)
- Bid / Lots5.0600/ 45
- Ask / Lots5.1800/ 10
- Open / Previous Close5.1600 / 5.1100
- Day Range
- 52 Week Range
- Volume253,900
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRMD |
|---|---|---|
| 09:32 ET | 4176 | 5.11 |
| 09:34 ET | 500 | 5.11 |
| 09:36 ET | 1000 | 5.12 |
| 09:39 ET | 100 | 5.1 |
| 09:41 ET | 700 | 5.11 |
| 09:43 ET | 808 | 5.13 |
| 09:45 ET | 1300 | 5.1317 |
| 09:48 ET | 100 | 5.13 |
| 09:50 ET | 890 | 5.105 |
| 09:52 ET | 621 | 5.105 |
| 09:54 ET | 100 | 5.095 |
| 09:57 ET | 1243 | 5.09 |
| 09:59 ET | 200 | 5.08 |
| 10:01 ET | 4239 | 5.1 |
| 10:03 ET | 1849 | 5.1 |
| 10:06 ET | 402 | 5.09 |
| 10:08 ET | 600 | 5.09 |
| 10:10 ET | 2000 | 5.0979 |
| 10:12 ET | 4633 | 5.1185 |
| 10:14 ET | 2108 | 5.13 |
| 10:15 ET | 4374 | 5.15 |
| 10:19 ET | 7516 | 5.17 |
| 10:21 ET | 458 | 5.15 |
| 10:24 ET | 2200 | 5.16 |
| 10:26 ET | 646 | 5.17 |
| 10:30 ET | 430 | 5.18 |
| 10:32 ET | 1600 | 5.17 |
| 10:35 ET | 1730 | 5.155 |
| 10:37 ET | 800 | 5.16 |
| 10:42 ET | 100 | 5.15 |
| 10:44 ET | 300 | 5.16 |
| 10:46 ET | 2265 | 5.155 |
| 10:48 ET | 400 | 5.1599 |
| 10:50 ET | 2840 | 5.165 |
| 10:51 ET | 1621 | 5.14 |
| 10:53 ET | 710 | 5.14 |
| 10:57 ET | 1200 | 5.14 |
| 11:02 ET | 500 | 5.14 |
| 11:04 ET | 100 | 5.145 |
| 11:06 ET | 400 | 5.14 |
| 11:08 ET | 4957 | 5.145 |
| 11:09 ET | 974 | 5.135 |
| 11:11 ET | 1844 | 5.135 |
| 11:13 ET | 400 | 5.14 |
| 11:15 ET | 100 | 5.14 |
| 11:22 ET | 100 | 5.13 |
| 11:27 ET | 100 | 5.13 |
| 11:36 ET | 3300 | 5.135 |
| 11:40 ET | 2048 | 5.13 |
| 11:42 ET | 2952 | 5.115 |
| 11:44 ET | 2565 | 5.125 |
| 11:45 ET | 150 | 5.1259 |
| 11:47 ET | 203 | 5.12 |
| 11:49 ET | 3350 | 5.115 |
| 11:51 ET | 1453 | 5.115 |
| 11:54 ET | 800 | 5.09 |
| 11:56 ET | 100 | 5.095 |
| 12:00 ET | 100 | 5.09 |
| 12:02 ET | 2619 | 5.105 |
| 12:07 ET | 210 | 5.105 |
| 12:12 ET | 500 | 5.115 |
| 12:14 ET | 300 | 5.125 |
| 12:16 ET | 1320 | 5.121 |
| 12:20 ET | 300 | 5.137 |
| 12:21 ET | 831 | 5.1218 |
| 12:25 ET | 1190 | 5.13 |
| 12:30 ET | 100 | 5.12 |
| 12:34 ET | 1510 | 5.13 |
| 12:36 ET | 2343 | 5.13 |
| 12:39 ET | 200 | 5.12 |
| 12:43 ET | 200 | 5.12 |
| 12:45 ET | 1600 | 5.13 |
| 12:48 ET | 200 | 5.1399 |
| 12:50 ET | 2830 | 5.125 |
| 12:52 ET | 126 | 5.125 |
| 12:54 ET | 1300 | 5.12 |
| 12:56 ET | 800 | 5.11 |
| 12:57 ET | 400 | 5.11 |
| 01:01 ET | 1100 | 5.1 |
| 01:03 ET | 100 | 5.105 |
| 01:06 ET | 1271 | 5.104 |
| 01:08 ET | 200 | 5.1 |
| 01:12 ET | 100 | 5.1 |
| 01:15 ET | 1020 | 5.12 |
| 01:26 ET | 544 | 5.122 |
| 01:30 ET | 100 | 5.12 |
| 01:32 ET | 100 | 5.12 |
| 01:33 ET | 100 | 5.12 |
| 01:35 ET | 300 | 5.125 |
| 01:39 ET | 591 | 5.1276 |
| 01:44 ET | 1150 | 5.125 |
| 01:48 ET | 300 | 5.12 |
| 01:53 ET | 752 | 5.11 |
| 02:00 ET | 3038 | 5.115 |
| 02:02 ET | 100 | 5.1159 |
| 02:04 ET | 1000 | 5.11 |
| 02:06 ET | 2099 | 5.1 |
| 02:08 ET | 1400 | 5.1059 |
| 02:09 ET | 200 | 5.1 |
| 02:13 ET | 300 | 5.1 |
| 02:18 ET | 200 | 5.105 |
| 02:20 ET | 200 | 5.1 |
| 02:22 ET | 100 | 5.105 |
| 02:27 ET | 3274 | 5.08 |
| 02:29 ET | 700 | 5.07 |
| 02:33 ET | 3233 | 5.07 |
| 02:36 ET | 200 | 5.06 |
| 02:38 ET | 200 | 5.06 |
| 02:40 ET | 1299 | 5.06 |
| 02:42 ET | 622 | 5.055 |
| 02:44 ET | 400 | 5.06 |
| 02:45 ET | 1677 | 5.0501 |
| 02:47 ET | 150 | 5.055 |
| 02:49 ET | 2182 | 5.054 |
| 02:51 ET | 100 | 5.055 |
| 02:56 ET | 1664 | 5.055 |
| 02:58 ET | 100 | 5.055 |
| 03:00 ET | 200 | 5.055 |
| 03:02 ET | 200 | 5.055 |
| 03:03 ET | 3399 | 5.04 |
| 03:05 ET | 1263 | 5.045 |
| 03:07 ET | 1258 | 5.051 |
| 03:12 ET | 100 | 5.056 |
| 03:16 ET | 1256 | 5.04 |
| 03:18 ET | 1444 | 5.055 |
| 03:20 ET | 700 | 5.065 |
| 03:21 ET | 100 | 5.0552 |
| 03:23 ET | 100 | 5.0542 |
| 03:25 ET | 700 | 5.06 |
| 03:27 ET | 200 | 5.0639 |
| 03:32 ET | 100 | 5.065 |
| 03:34 ET | 200 | 5.0661 |
| 03:36 ET | 200 | 5.06 |
| 03:38 ET | 300 | 5.06 |
| 03:39 ET | 900 | 5.07 |
| 03:41 ET | 595 | 5.07 |
| 03:43 ET | 981 | 5.07 |
| 03:45 ET | 1920 | 5.075 |
| 03:48 ET | 2076 | 5.07 |
| 03:50 ET | 479 | 5.075 |
| 03:52 ET | 200 | 5.07 |
| 03:54 ET | 100 | 5.07 |
| 03:56 ET | 7758 | 5.09 |
| 03:57 ET | 3669 | 5.11 |
| 03:59 ET | 41442 | 5.12 |
May 13, 2024
DJ CorMedix Price Target Maintained With a $10.00/Share by Needham, from 5:42AM ET on Monday May 13, 2024 by Dow Jones
5:42AM ET on Monday May 13, 2024 by Dow Jones
May 10, 2024
CorMedix Inc. to Participate in Two Upcoming Investor Conferences, from 8:30AM ET on Friday May 10, 2024 by Dow Jones
8:30AM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update, from 7:30AM ET on Thursday May 09, 2024 by Dow Jones
7:30AM ET on Thursday May 09, 2024 by Dow Jones*DJ CorMedix 1Q Loss/Shr 25c >CRMD, from 7:30AM ET on Thursday May 09, 2024 by Dow Jones
7:30AM ET on Thursday May 09, 2024 by Dow Jones
May 6, 2024
CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024, from 8:30AM ET on Monday May 06, 2024 by Dow Jones
8:30AM ET on Monday May 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CorMedix Inc | 281.0M | -5.5x | --- |
Cipla Ltd | 14.4B | 0.0x | --- |
Zevra Therapeutics Inc | 187.9M | -3.5x | --- |
Dbv Technologies SA | 129.4M | -1.5x | --- |
Assembly Biosciences Inc | 81.3M | -1.3x | --- |
Incannex Healthcare Inc | 42.9M | 0.0x | --- |
Company Information
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Contact Information
- Headquarters
- 300 Connell Drive, Suite 4200BERKELEY HEIGHTS, NJ, United States 07922
- Phone
- 908-517-9500
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Myron Kaplan
- Chief Executive Officer, Director
- Joseph Todisco
- Chief Financial Officer, Executive Vice President
- Matthew David
- Executive Vice President, Head of Clinical and Medical Affairs
- Elizabeth Massonhurlburt
- Executive Vice President, Chief Commercial Officer
- Erin Mistry
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $281.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 55.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.72 |
EPS | $-0.93 |
Book Value | $1.28 |
P/E Ratio | -5.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
